Robert F. Kennedy Jr-revamped vaccine panel to re-examine childhood immunization schedule, raising alarm
On Wednesday (June 25), the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under its new chair, Martin Kulldorff.
Kulldorff announced the creation of two new work groups: one to scrutinize the cumulative effects of all recommended vaccines in children and adolescents, and another to review vaccines that have not been evaluated in more than seven years.
'The number of vaccines that our children and adolescents receive today exceeds what children in most other developed nations receive and what most of us in this room received when we were children,' Kulldorff said during the meeting.
He added: 'In addition to studying and evaluating individual vaccines, it is important to evaluate the cumulative effect of the recommended vaccine schedule. This includes interaction effects between different vaccines, the total number of vaccines, cumulative amount of vaccine ingredients, and relative timing.'
Kulldorff explained that among the topics the committee could consider is whether hepatitis B shots should continue to be administered to newborns before hospital discharge.
The group may also weigh the possibility of recommending separate measles, mumps, and rubella (MMR) and varicella vaccines instead of the combined MMRV shot, and look at adjusting the timing of MMR doses to address certain religious objections.
'This was supposed to be a regular practice of the ACIP, but it has not been done in a thorough and systematic way,' Kulldorff said. 'We are learning more about vaccines over time, and to stay true to evidence-based medicine, we have a duty and a responsibility to keep up to date with scientific research.'
Earlier this month, Health Secretary Robert F. Kennedy Jr. removed all 17 members of the previous ACIP and appointed eight new members, many of whom have voiced skepticism about childhood vaccines.
'When I was a kid I got three vaccines,' Kennedy said. 'Today they get 69 to 92 jabs of vaccines between conception and when they are 18 years old.'
Kennedy has frequently claimed that today's vaccination schedule is excessive and not sufficiently scrutinised.
The American Academy of Pediatrics (AAP) swiftly condemned the developments. In a video statement, the AAP said: 'Immunization policy through ACIP is no longer a credible process.'
The group pledged to continue publishing its own independent vaccine recommendations for children, regardless of ACIP deliberations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
6 hours ago
- Economic Times
COVID wave is moving across USA: Health experts warn parents that children must do this
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads FAQs Tired of too many ads? Remove Ads United States of America is witnessing a late-summer COVID wave, even as children are preparing to return to school. Fortunately, hospitalization rates remain low. The risk of severe illness and hospitalization among children younger than 1 who are infected with the coronavirus is comparable to that among adults 65 and older. That's why experts have said that a child's first exposure should be through a vaccine, rather than infection. However, this fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID, as per a health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2. Among children ages 6 months to 2 years who were hospitalized with COVID from October 2022 to April 2024, more than half had no underlying medical conditions, according to data from the CDC, NYT News Service reported. Pfizer 's vaccine has long been available to these children under so-called emergency use authorization. But the Food and Drug Administration is considering discontinuing the authorization for that age group, according to an email sent by the Centers for Disease Control and Prevention to state and local health confirmed the possibility Monday evening and said that the company was "currently in discussions with the agency on potential paths forward." For children 5 to 11 years old, the Pfizer vaccine is expected to be approved and available, according to the CDC's email, which was reviewed by The New York July, the FDA granted full approval to Moderna's COVID vaccine for children -- but only for those who have health conditions that may put them at increased risk should they become infected. Novavax's COVID vaccine has never been available for children younger than upshot is that if the FDA does not renew Pfizer's authorization for children 6 months to 4 years, or fully approve the vaccine, healthy children in that age group will have no officially sanctioned options -- although doctors may still choose to provide the vaccine "off label."In May, Health Security Robert F. Kennedy Jr. announced that COVID vaccines would no longer be offered to healthy children or pregnant women. Kennedy has called the Pfizer and Moderna vaccines dangerous. In May 2021, in the thick of the pandemic, he filed a petition with the FDA demanding that the agency revoke authorization for the CDC, which typically makes such recommendations, later walked back the secretary's statement, saying that healthy children could get the shot if a doctor agreed that it was told the CDC it was ramping up supplies of its vaccine for the fall, according to the agency's email. But it is not approved for healthy children, and if the FDA rescinds authorization for children younger than 5, parents of healthy children will find themselves with no Nixon, a spokesperson for the Department of Health and Human Services, declined to comment on potential regulatory changes and said any reports before an official statement should be treated as "speculation."But public health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2. Among children ages 6 months to 2 years who were hospitalized with COVID from October 2022 to April 2024, more than half had no underlying medical conditions, according to data from the vaccines have also been shown to offer modest protection against long COVID in some children. The effects are already becoming apparent. Providers have stopped ordering last year's shot, as they often do at this time of the year. Normally by this point, there would be a clear plan for the 2025-26 season.A1. The full form of CDC is Centers for Disease Control and Prevention.A2. Full form of FDA is Food and Drug Administration.
Time of India
6 hours ago
- Time of India
COVID wave is moving across USA: Health experts warn parents that children must do this
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads FAQs Tired of too many ads? Remove Ads United States of America is witnessing a late-summer COVID wave, even as children are preparing to return to school. Fortunately, hospitalization rates remain low. The risk of severe illness and hospitalization among children younger than 1 who are infected with the coronavirus is comparable to that among adults 65 and older. That's why experts have said that a child's first exposure should be through a vaccine, rather than infection. However, this fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID, as per a health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2. Among children ages 6 months to 2 years who were hospitalized with COVID from October 2022 to April 2024, more than half had no underlying medical conditions, according to data from the CDC, NYT News Service reported. Pfizer 's vaccine has long been available to these children under so-called emergency use authorization. But the Food and Drug Administration is considering discontinuing the authorization for that age group, according to an email sent by the Centers for Disease Control and Prevention to state and local health confirmed the possibility Monday evening and said that the company was "currently in discussions with the agency on potential paths forward." For children 5 to 11 years old, the Pfizer vaccine is expected to be approved and available, according to the CDC's email, which was reviewed by The New York July, the FDA granted full approval to Moderna's COVID vaccine for children -- but only for those who have health conditions that may put them at increased risk should they become infected. Novavax's COVID vaccine has never been available for children younger than upshot is that if the FDA does not renew Pfizer's authorization for children 6 months to 4 years, or fully approve the vaccine, healthy children in that age group will have no officially sanctioned options -- although doctors may still choose to provide the vaccine "off label."In May, Health Security Robert F. Kennedy Jr. announced that COVID vaccines would no longer be offered to healthy children or pregnant women. Kennedy has called the Pfizer and Moderna vaccines dangerous. In May 2021, in the thick of the pandemic, he filed a petition with the FDA demanding that the agency revoke authorization for the CDC, which typically makes such recommendations, later walked back the secretary's statement, saying that healthy children could get the shot if a doctor agreed that it was told the CDC it was ramping up supplies of its vaccine for the fall, according to the agency's email. But it is not approved for healthy children, and if the FDA rescinds authorization for children younger than 5, parents of healthy children will find themselves with no Nixon, a spokesperson for the Department of Health and Human Services, declined to comment on potential regulatory changes and said any reports before an official statement should be treated as "speculation."But public health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2. Among children ages 6 months to 2 years who were hospitalized with COVID from October 2022 to April 2024, more than half had no underlying medical conditions, according to data from the vaccines have also been shown to offer modest protection against long COVID in some children. The effects are already becoming apparent. Providers have stopped ordering last year's shot, as they often do at this time of the year. Normally by this point, there would be a clear plan for the 2025-26 season.A1. The full form of CDC is Centers for Disease Control and Prevention.A2. Full form of FDA is Food and Drug Administration.
The Hindu
8 hours ago
- The Hindu
Health Matters newsletter: The fate of the mRNA vaccine
On the U.S. halting mRNA vaccine contracts, setbacks in disease eradication, WHO health updates, lifestyle and nutrition research, advances in cancer care, environmental health risks and more The biggest story this week, not just in our neck of the woods, but globally is the U.S.'s position on mRNA vaccines .Why, because the United States, has over the years inveigled itself into a position of leadership in health care research and much of the research, worldwide, is led or funded or developed upon by scientists in that country. When Robert F. Kennedy Junior, a steady figure in our columns, decided to axe mRNA vaccine contracts, he cited safety concerns. The US will terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology that was actually credited with helping end the Covid pandemic and saving millions of lives. Tragically, Mr. Kennedy said: 'We reviewed the science, listened to the experts, and acted.' The US health department's Biomedical Advanced Research and Development Authority claimed the data shows these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. Without further clarity, he said, the US would be 'shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.' In total, the affected projects are worth 'nearly $500 million,' the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move 'to preserve prior taxpayer investment.' Meanwhile, in related news, health experts and lawyers worry that Mr. Kennedy's changes will reflect his history as a leader in the anti-vaccine movement, which has alternately called for abolishing the program or expanding it to cover unproven injuries and illnesses that aren't connected to vaccines. He has, for a while now, been vowing to 'fix' the federal programme for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by anti-vaccine activists. 'Kennedy and other critics believe the programme is 'too miserly in what it considers to be a vaccine injury,' said Jason Schwartz, a public health expert at Yale University. 'That's created great concern that he could expand what's included.' Nearly every week we hear of the resurgence of an infectious disease, in parts of the world it had not emerged for decades. This article, World nearly beat polio but fake records, imperfect vaccine, missteps aided its comeback , is an important story recording what went wrong where. The World Health Organization (WHO) and partners embarked on their polio campaign in 1988 with the bold goal of eradication — a feat seen only once for human diseases, with smallpox in 1980. They came close several times, including in 2021, when just five cases of the natural virus were reported in Pakistan and Afghanistan. But since then, cases rebounded, hitting 99 last year, and officials have missed at least six self-imposed eradication deadlines. The AP, reported in a story that the Global Polio Eradication Initiative was derailed by mismanagement and what insiders describe as blind allegiance to an outdated strategy and a problematic oral vaccine. If we talk infectious diseases, can TB be far behind? The WHO called for research scale-up towards ending TB in South-East Asia region which continues to bear nearly half of the global TB burden, accounting for the highest share of cases and deaths worldwide. Bindu Shajan Perappadan reports that the WHO updated COVID-19 guidelines: antibiotics advised only with suspected bacterial infection . For patients with mild or non-severe COVID-19 and low suspicion of bacterial infection, WHO strongly recommends against empirical antibiotic use. Here's another interesting development in the sector : Scientists identify how children develop immunity to bacterial infection, paving way for vaccine s The National Organ Transplant Organisation's advisory last week that Women, kin of deceased donors should get priority in organ transplant , s eems to have set the cat among the pigeons. While it's a laudable objective to make sure that the gender imbalance is corrected, there should be care taken to ensure that this won't create a backdoor opportunity for out-of-order allocations. Dr. Idayachandran N. tells you why it is essential to register to become an organ donor? Switching on to another column favourite - non communicable diseaes, Anirban Mukhopadhyay had a clarifying article on urbanisation has a prime role in contributing to the NCD epidemic: How migration to urban areas is expanding waistlines in India . In a recent analysis of over 31,000 adults aged 45 and above, researchers Bittu Mandal and Kalandi Charan Prasad at the Indian Institute of Technology, Indore report a strong link between rural-to-urban migration and obesity. The longer someone lives in a city, the more likely they are to carry excess weight—especially around the waist, the fat most tied to chronic disease. Migration, they suggest, is not just demographic—it's metabolic. R. Prasad writes on an experiment: eating 250 grams of mangoes instead of bread for breakfast led to improved glycaemic control in diabetics . One of the main reasons why participants in the treatment groups showed improved glycaemic control is because of the relatively less glycaemic index of mango compared with white bread. Food items with lower glycaemic index are less likely to significantly spike blood sugar levels when consumed in moderation. In addition, the fibre content in mangoes contributes to slower glucose absorption. Preeti Zachariah asks Jack Mosley, the author of Food Noise: How weight loss medications & smart nutrition can silence your craving these questions: Why is it becoming harder to lose weight? And should Ozempic step in where willpower fails ? Hit on the link to read more. Dr. Sameer Chaudhari looks at osteoporosis from a preventative aspect. Today, technology is so advanced that it is possible to rebuild bone strength even after osteoporosis has set in - something once thought impossible. Afshan Yasmeen threw light on a very key aspect of the mass IT layoffs of young professionals . She explains elaborately the impact that this is likely to have on their mental health, and those of their families. Sudheer Kumar Shukla's piece is an eye opener on how groundwater contamination is fuelling chronic illnesses in India. He recommends that a multi-sectoral approach be channeled to ensure that the water we drink is safe for consumption. The rare disease sector can also benefit from some creative multi-sectoral approaches. Geetha Srimathi S. outlines the plight of persons with rare diseases in India who struggle without sustainable access to drugs . The dimensions of the problem are so massive, that no single agency is likely to sort out the issue, and present sustainable, lasting solutions. August 18th is recognised as World Breast Cancer Research Day, and to mark the day, Serena Josephine M. writes on how Advances in breast cancer treatments bring in a range of benefits for patients . Over the past decade, there has been a significant advancement in the ability to detect and treat breast cancer in terms of both expertise and technology, but also in treatment methodologies - improving precision and conserving non-cancerous tissues better. Dr. Srinivas Chilukuri further elaborates on this, focussing on Beating lung cancer with precision: the evolving role of radiation therapy , as August 1 marked World Lung Cancer Day. This week, a piece by Dr. Christianez Ratna Kiruba elaborated on the hospital referral system in India , how it is broken, not functioning as it must, and does not necessarily always mean recovery or relief for the patient. Our tail piece of the week is Friday's Health Wrap. This time, it brings to you information about yet another rare blood group, mental health crises consequent to the mass lay offs, and water quality. We had an expert - senior orthopaedic surgeon Dr. Ajit Yadav who gave a few tips on preserving bone health early in life. Do tune in on The Hindu's YouTube channel . In our explainers series, this week, here's all you need to know about E ctopic pregnancies - Zubeda Hamid writes Psoriasis - What are the causes and how do you treat the condition - R. Sujatha explains. What is the Cervical Pessary - Athira Elsa Johnsson writes. She also explains How ovarian health impacts the body beyond fertility Dr. K. Ganapathy explains how to recognise dangerous headaches . Dr. Tulika Seth brings to light advances in treatment for haemophilia to Prevent bleeds before they happen . Dr. J. D. Mukherji talks about what needs to change in order for multiple sclerosis to be properly diagnosed in India. If you have a few extra moments, also stop by at the following articles: Zubeda Hamid Science Quiz: On immunity Japan firm seeks approval for stem cell treatment for Parkinson's Lithium deficiency could lead to Alzheimer's , study suggests Pavlov's Nobel Prize-winning research on digestion and its lasting impact on physiology and neurobiology—-
